China Renewable Design for Bristol-Myers Squibb - Fmoc-D-Cys(Trt)-OH Cas:167015-11-4 – XD BIOCHEM Manufacturer and Supplier

Renewable Design for Bristol-Myers Squibb - Fmoc-D-Cys(Trt)-OH Cas:167015-11-4 – XD BIOCHEM

Short Description:

Order or Request Quote

Product Detail

Product Tags

Feedback (2)

We insist on offering high-quality creation with superior business enterprise concept, honest revenue plus the greatest and fast service. it will bring you not only the high quality solution and huge profit, but essentially the most significant is usually to occupy the endless market for Dna-Encoded Library Technology (Delt), Ddp, Complex Conjugates, We have professional products knowledge and rich experience on manufacturing. We always believe your success is our business!

Renewable Design for Bristol-Myers Squibb - Fmoc-D-Cys(Trt)-OH Cas:167015-11-4 – XD BIOCHEM Detail:

Catalog Number	XD91480
Product Name	Fmoc-D-Cys(Trt)-OH
CAS	167015-11-4
Molecular Formula	C37H31NO4S
Molecular Weight	585.71
Storage Details	2-8°C
Harmonized Tariff Code	2922499990

Product Specification

Appearance	White powder
Assay	99% min

Product detail pictures:

Related Product Guide:

Our organization insists all along the quality policy of "product quality is base of business survival; purchaser gratification is the staring point and ending of an business; persistent improvement is eternal pursuit of staff" as well as the consistent purpose of "reputation 1st, purchaser first" for Renewable Design for Bristol-Myers Squibb - Fmoc-D-Cys(Trt)-OH Cas:167015-11-4 – XD BIOCHEM , The product will supply to all over the world, such as: Angola, Mongolia, Oslo, We adopt advanced production equipment and technology, and perfect testing equipment and methods to ensure our product quality. With our high-level talents, scientific management, excellent teams, and attentive service, our products are favored by domestic and foreign customers. With your support, we will build a better tomorrow!

Amgen

Bevacizumab

Cosmetic Raw Materials

Oncology Drugs

Patent Expired

Pd-L1 Tumor Immunotherapy

This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!